SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (778)12/28/1999 9:34:00 PM
From: Biotech Jim   of 3158
 
I agree completely with your thoughts as to why there were few buyouts of the 2nd or 3rd tiers. They have to want to be taken out. However,

"Same with SNAP, from another point of view --- decent cash and no big clinical trial drain on cash."

As to the latter thought about the lack of clinical trials, I would think that therein lies the problem as to why there has not been much price appreciation as well as their burn. Great molecular biology, but their collaborations seem not to get renewed.

BJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News